Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, United States.
Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States.
Front Immunol. 2021 Oct 20;12:757811. doi: 10.3389/fimmu.2021.757811. eCollection 2021.
Induction of broadly neutralizing antibodies (bNAbs) is a major goal for HIV vaccine development. HIV envelope glycoprotein (Env)-specific bNAbs isolated from HIV-infected individuals exhibit substantial somatic hypermutation and correlate with T follicular helper (Tfh) responses. Using the VC10014 DNA-protein co-immunization vaccine platform consisting of gp160 plasmids and gp140 trimeric proteins derived from an HIV-1 infected subject that developed bNAbs, we determined the characteristics of the Env-specific humoral response in vaccinated rhesus macaques in the context of CD4+ T cell depletion. Unexpectedly, both CD4+ depleted and non-depleted animals developed comparable Tier 1 and 2 heterologous HIV-1 neutralizing plasma antibody titers. There was no deficit in protection from SHIV challenge, no diminution of titers of HIV Env-specific cross-clade binding antibodies, antibody dependent cellular phagocytosis, or antibody-dependent complement deposition in the CD4+ depleted animals. These collective results suggest that in the presence of diminished CD4+ T cell help, HIV neutralizing antibodies were still generated, which may have implications for developing effective HIV vaccine strategies.
诱导广谱中和抗体(bNAb)是 HIV 疫苗开发的主要目标。从 HIV 感染者中分离出的 HIV 包膜糖蛋白(Env)特异性 bNAb 表现出大量体细胞超突变,与滤泡辅助 T 细胞(Tfh)反应相关。我们使用由来自感染 HIV 的个体产生 bNAb 的 gp160 质粒和 gp140 三聚体蛋白组成的 VC10014 DNA-蛋白联合免疫疫苗平台,在 CD4+T 细胞耗竭的情况下,确定了接种恒河猴中 Env 特异性体液免疫反应的特征。出乎意料的是,CD4+耗尽和非耗尽的动物都产生了可比的 1 型和 2 型异源 HIV-1 中和血浆抗体滴度。在 SHIV 挑战中没有保护不足,CD4+耗尽动物的 HIV Env 特异性交叉谱系结合抗体、抗体依赖性细胞吞噬作用或抗体依赖性补体沉积的滴度没有降低。这些综合结果表明,在 CD4+T 细胞辅助减少的情况下,仍产生了 HIV 中和抗体,这可能对开发有效的 HIV 疫苗策略具有重要意义。